Skip to content

PRF Technologies Ltd.

PRFX

CIK 0001801834 · Pharmaceutical Preparations · Nasdaq

  • PAINREFORM LTD. (until 2026-01-20)
← back to feed
Revenue (TTM)
$17K
FY Dec 2025
Net Income (TTM)
−$5.02M
+65.6% YoY FY Dec 2025
EPS Diluted (TTM)
−$7.47
+92.9% YoY FY Dec 2025
Gross Margin
-311.8%
FY Dec 2025
Operating Margin
-30,129.4%
FY Dec 2025
Net Margin
-29,541.2%
FY Dec 2025
Free Cash Flow (TTM)
−$3.96M
FY Dec 2025
Cash
$3.13M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
830.61K sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings